Go Pro

Eupraxia Pharmaceuticals (EPRX) Institutional Ownership

Eupraxia Pharmaceuticals logo
$6.60 +0.12 (+1.82%)
As of 09:45 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Eupraxia Pharmaceuticals (NASDAQ:EPRX)

Number of
Institutional Buyers
(last 12 months)
32
Total
Institutional Inflows
(last 12 months)
$61.84M
Number of
Institutional Sellers
(last 12 months)
4
Total
Institutional Outflows
(last 12 months)
$5.77M
Get EPRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Eupraxia Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

EPRX Institutional Buying and Selling by Quarter

Eupraxia Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/7/2026 BlackRock Inc.6,088$40K0.0%N/A0.009%
8/7/2026 Persistent Asset Partners Ltd3,791$25K0.0%N/A0.006%
6/4/2026Seven Fleet Capital Management LP709,515$5.14M1.6%N/A1.091%
6/3/2026DV Trading LLC276,000$2.00M0.0%N/A0.457%
5/19/2026Bank of America Corp DE268,221$1.94M0.0%+5.9%0.444%
5/19/2026Ally Bridge Group NY LLC660,375$4.78M3.9%+66.0%1.093%
5/18/2026Royal Bank of Canada261,376$1.89M0.0%+33.2%0.433%
5/18/2026Redmile Group LLC700,000$5.07M0.3%N/A1.158%
5/18/2026Rubric Capital Management LP691,170$5.00M0.1%N/A1.144%
5/16/2026SummitTX Capital L.P.327,997$2.38M0.1%+86.4%0.543%
5/15/2026Affinity Asset Advisors LLC1,589,005$11.50M0.6%+429.7%2.629%
2/18/2026XTX Topco Ltd16,180$122K0.0%N/A0.045%
2/18/2026Ikarian Capital LLC610,000$4.61M0.4%N/A1.696%
2/18/2026Squadron Capital Management LLC500,000$3.78M1.6%N/A1.390%
2/18/2026SummitTX Capital L.P.175,948$1.33M0.0%N/A0.489%
2/18/2026 Quadrature Capital Ltd43,186$326K0.0%N/A0.120%
2/18/2026Boothbay Fund Management LLC156,331$1.18M0.0%N/A0.435%
2/17/2026Ally Bridge Group NY LLC397,895$3.00M3.1%-56.5%1.106%
2/17/2026Guardian Wealth Advisors LLC NC10,000$76K0.0%N/A0.028%
2/17/2026Royal Bank of Canada196,277$1.48M0.0%-54.2%0.546%
2/16/2026Aptus Capital Advisors LLC10,000$76K0.0%N/A0.028%
2/13/2026Marshall Wace LLP158,133$1.19M0.0%N/A0.440%
2/13/2026Ingalls & Snyder LLC77,400$584K0.0%+31.0%0.215%
2/12/2026Jane Street Group LLC29,622$223K0.0%N/A0.082%
2/10/2026Cibc World Market Inc.58,050$437K0.0%+287.0%0.161%
2/10/2026Goldman Sachs Group Inc.58,058$438K0.0%+44.8%0.161%
2/9/2026Geode Capital Management LLC13,899$105K0.0%N/A0.039%
1/1/2026JPMorgan Chase & Co.16,467$97K0.0%-12.0%0.046%
11/17/2025Alyeska Investment Group L.P.250,000$1.48M0.0%N/A0.695%
11/17/2025Vivo Capital LLC1,350,000$7.97M0.6%N/A3.754%
11/17/2025Velan Capital Investment Management LP352,000$2.08M2.0%N/A0.979%
11/17/2025Integrated Wealth Concepts LLC12,000$71K0.0%N/A0.033%
11/17/2025Bank of America Corp DE45,577$269K0.0%+262.9%0.127%
11/17/2025Ally Bridge Group NY LLC915,000$5.40M3.3%N/A2.544%
11/14/2025Raymond James Financial Inc.33,373$197K0.0%+173.3%0.093%
11/14/2025 Scotia Capital Inc.1,277,885$7.26M0.0%-1.1%3.554%
11/13/2025UBS Group AG95,756$565K0.0%+155.4%0.266%
11/13/2025 Guardian Partners Inc.24,130$147K0.0%N/A0.067%
11/7/2025Ingalls & Snyder LLC59,100$349K0.0%+58.9%0.164%
11/7/2025JPMorgan Chase & Co.16,467$97K0.0%-12.0%0.046%
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company (Ad)

We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel

👉 Unlock the ticker now and get it completely free.
10/14/2025 TCI Wealth Advisors Inc.11,000$65K0.0%N/A0.031%
8/15/2025Bank of America Corp DE12,559$72K0.0%+402.4%0.035%
8/13/2025 Quadrature Capital Ltd10,700$61K0.0%N/A0.030%
8/13/2025 Scotia Capital Inc.1,291,989$6.98M0.0%-16.8%3.593%
8/12/2025JPMorgan Chase & Co.18,717$108K0.0%+593.2%0.052%
8/11/2025 TD Waterhouse Canada Inc.9,600$56K0.0%-90.9%0.027%
8/5/2025Bank of Montreal Can37,250$215K0.0%-28.7%0.104%
7/31/2025Ingalls & Snyder LLC37,200$214K0.0%N/A0.103%
5/15/2025Royal Bank of Canada342,828$1.13M0.0%+21.1%0.956%
5/9/2025Scotia Capital Inc.1,552,679$5.07M0.0%+11.6%4.331%
2/17/2025Millennium Management LLC10,000$31K0.0%N/A0.028%
2/13/2025Scotia Capital Inc.1,391,719$4.26M0.0%-0.3%3.907%
2/13/2025Raymond James Financial Inc.11,613$37K0.0%N/A0.033%
2/13/2025Bank of Montreal Can56,750$178K0.0%+15.2%0.159%
2/6/2025Raymond James Financial Inc.11,613$37K0.0%N/A0.033%
7/17/2024180 Wealth Advisors LLC13,000$34K0.0%N/A0.048%


EPRX Institutional Ownership - Frequently Asked Questions

During the previous two years, 37 institutional investors and hedge funds held shares of Eupraxia Pharmaceuticals. The most heavily invested institutionals were Affinity Asset Advisors LLC ($11.50M), Vivo Capital LLC ($7.97M), Scotia Capital Inc. ($7.26M), Seven Fleet Capital Management LP ($5.14M), Redmile Group LLC ($5.07M), Rubric Capital Management LP ($5.00M), and Ally Bridge Group NY LLC ($4.78M).Learn more on Eupraxia Pharmaceuticals' institutional investors.

Of the 36 institutional investors that purchased Eupraxia Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vivo Capital LLC ($1.35M), Affinity Asset Advisors LLC ($1.29M), Ally Bridge Group NY LLC ($1.18M), Seven Fleet Capital Management LP ($709.52K), Redmile Group LLC ($700K), Rubric Capital Management LP ($691.17K), and Ikarian Capital LLC ($610K).

Institutional investors have bought a total of 9,031,229 shares in the last 24 months. This purchase volume represents approximately $61.84M in transactions.

The following institutional investors have sold Eupraxia Pharmaceuticals stock in the last 24 months: Ally Bridge Group NY LLC ($517.11K), Royal Bank of Canada ($232.53K), Scotia Capital Inc. ($14.10K), and JPMorgan Chase & Co. ($4.50K).

Institutional investors have sold a total of 768,236 shares in the last 24 months. This volume of shares sold represents approximately $5.77M in transactions.



Institutional ownership data for NASDAQ:EPRX is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/7/2026. New 13F filings are added each quarter as they're published.
From Our Partners